During non-clinical and clinical development phases of pharmaceuticals, toxicology is particularly relevant to the safety of humans. Potential adverse effects of a substance on the human body which may lead to long-term impact are to be carefully determined.
It is vital to explore potential toxicities in industry, such as occupational exposure (OEL) to hazardous materials and industrial chemicals. Health-based exposure limits (HBEL) are frequently established by our toxicology experts for use in risk identification for humans. A full list of toxicology-related services is provided below.
Our toxicologists have conducted numerous risk assessments concerning a wide variety of substances. With decades of experience, particularly in the pharma industry, our toxicology experts will assist you in the design of appropriate toxicology studies (e.g. acute to chronic toxicity, genotoxicity, carcinogenicity) and advise on world-wide regulatory pathways, in interpretation of results thereof, prepare risk assessments for extractables and leachables (e.g. extractables and leachables from primary containers), or hazard identification combined with a risk assessment for impurities and potential leachables. IASON experts understand toxicology findings generated in animals and also the potential relevance for humans. On demand, our toxicologists also take on project management for non-clinical safety studies with a new drug candidate.
Need more information on our services regarding toxicology? Call us now or write us using the link below.
Our toxicologists are always happy to help.